# Gene Expression Patterns in Lung Adenocarcinoma Cells in Response to Changes in Deuterium Concentration

**Authors:** Gabor I. Csonka, András Papp, Ildikó Somlyai, Gábor Somlyai

PMC · DOI: 10.3390/ijms262210969 · International Journal of Molecular Sciences · 2025-11-12

## TL;DR

Changing deuterium concentration in water affects gene expression in lung cancer cells, influencing oncogenic and drug-resistance pathways.

## Contribution

Identifies specific gene expression patterns in lung adenocarcinoma cells in response to varying deuterium concentrations.

## Key findings

- High deuterium (300 ppm) upregulates oncogenic and survival-related genes like EGFR and CD44.
- Deuterium-depleted water (40–80 ppm) downregulates oncogenes and drug-resistance genes such as MYCN and ABCB1.
- Dose-dependent responses in DNA repair and apoptosis genes suggest coordinated regulation by deuterium.

## Abstract

Deuterium, a stable isotope of hydrogen present in natural water at ~150 ppm, has been implicated in modulating cellular metabolism and tumor progression. While deuterium-depleted water (DDW) has shown anti-cancer effects in preclinical and clinical studies, the underlying transcriptional mechanisms remain incompletely defined. Here, we profiled gene expression in A549 lung adenocarcinoma cells cultured for 72 h in media containing four graded deuterium concentrations (40, 80, 150, and 300 ppm) using a targeted NanoString panel of 236 cancer-related genes. After stringent quality filtering, 87 genes were retained and classified into nine distinct expression patterns based on fold-change trends relative to the 150 ppm control. High deuterium (300 ppm) induced strong upregulation (up to 2.1-fold) of oncogenic and survival-related genes (e.g., EGFR, CTNNB1, STAT3, CD44), while DDW (40–80 ppm) led to selective downregulation (down to 0.58-fold) of oncogenes (e.g., MYCN, ETS2, IRF1) and drug-resistance genes (e.g., ABCB1). Se-veral genes involved in DNA repair, apoptosis, and extracellular matrix remodeling exhibited dose-dependent responses, suggesting coordinated regulation by deuterium abundance. These findings demonstrate that deuterium concentration functions as a biologically active variable capable of modulating cancer-relevant gene networks. This exploratory dataset refines mechanistic models of DDW action and provides a foundation for future studies incorporating biological replication, functional assays, and in vivo validation. Significance: Deuterium concentration modulation alters oncogenic, apoptotic, and drug-resistance gene networks in lung adenocarcinoma cells, refining prior models of deuterium-depleted water effects. These findings identify deuterium concentration as a biologically active variable warranting further mechanistic and translational investigation.

## Linked entities

- **Genes:** EGFR (epidermal growth factor receptor) [NCBI Gene 1956], CTNNB1 (catenin beta 1) [NCBI Gene 1499], STAT3 (signal transducer and activator of transcription 3) [NCBI Gene 6774], CD44 (CD44 molecule (IN blood group)) [NCBI Gene 960], MYCN (MYCN proto-oncogene, bHLH transcription factor) [NCBI Gene 4613], ETS2 (ETS proto-oncogene 2, transcription factor) [NCBI Gene 2114], IRF1 (interferon regulatory factor 1) [NCBI Gene 3659], ABCB1 (ATP binding cassette subfamily B member 1) [NCBI Gene 5243]
- **Chemicals:** deuterium (PubChem CID 24523), DDW (PubChem CID 71737799)
- **Diseases:** lung adenocarcinoma (MONDO:0005061)

## Full-text entities

- **Genes:** EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}, STAT3 (signal transducer and activator of transcription 3) [NCBI Gene 6774] {aka ADMIO, ADMIO1, APRF, HIES}, ABCB1 (ATP binding cassette subfamily B member 1) [NCBI Gene 5243] {aka ABC20, CD243, CLCS, ENPAT, GP170, MDR1}, MYCN (MYCN proto-oncogene, bHLH transcription factor) [NCBI Gene 4613] {aka FGLDS1, MODED, MPAPA, MYCNsORF, MYCNsPEP, N-myc}, CD44 (CD44 molecule (IN blood group)) [NCBI Gene 960] {aka CDW44, CSPG8, ECM-III, ECMR-III, H-CAM, HCELL}, IRF1 (interferon regulatory factor 1) [NCBI Gene 3659] {aka IMD117, IRF-1, MAR}, CTNNB1 (catenin beta 1) [NCBI Gene 1499] {aka CTNNB, EVR7, MRD19, NEDSDV, armadillo}, ETS2 (ETS proto-oncogene 2, transcription factor) [NCBI Gene 2114] {aka ETS2IT1}
- **Diseases:** cancer (MESH:D009369), Lung Adenocarcinoma (MESH:D000077192), drug (MESH:D000081015)
- **Chemicals:** water (MESH:D014867), DDW (-), hydrogen (MESH:D006859), Deuterium (MESH:D003903)
- **Cell lines:** A549 lung adenocarcinoma — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_WN45)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12652128/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12652128/full.md

## References

35 references — full list in the complete paper: https://tomesphere.com/paper/PMC12652128/full.md

---
Source: https://tomesphere.com/paper/PMC12652128